Mitotech Granted Orphan Drug Designation by FDA for Visomitin in LHON
The US Orphan Drug Designation would provide seven-year market exclusivity if Visomitin was approved for…
Month: December 2021
Verona Pharma Reports TQT Study Successfully Demonstrated No Clinically Relevant Effect on Cardiac Conduction
Study Supports Ongoing Phase 3 Program and Planned NDA Submission LONDON and RALEIGH, N.C., Dec….
invIOs goes live with unique cell therapy platform and clinical-stage immuno-oncology pipeline
VIENNA, Austria, Dec. 16, 2021 (GLOBE NEWSWIRE) — invIOs (innovative Immuno-Oncology) GmbH, a privately held…
Anaveon to raise CHF 110 million in oversubscribed Series B financing
– Leading international syndicate led by Forbion and corner-stoned by founding investor Syncona– Confirms depth…
InnoSkel awarded Innovation Passport by the UK MHRA for the treatment of a rare bone disorder
InnoSkel awarded Innovation Passport by the UK MHRA for the treatment of a rare bone…
Zealand Pharma Announces Enrollment of Last Patient Needed for Interim Analysis of EASE-SBS 1 Phase 3 Trial Assessing Glepaglutide in Patients with Short Bowel Syndrome
Company announcement – No. 76 / 2021 Zealand Pharma Announces Enrollment of Last Patient Needed…
Novadiscovery expands Janssen collaboration by implementing its JINKO® clinical trial simulation platform for the development of lung cancer models
Novadiscovery expands Janssen collaboration by implementing its JINKO® clinical trial simulation platform for the development…
Press Release: Gilles SCHNEPP takes over as Chairman of the Appointments, Governance and CSR Committee of Sanofi
Gilles SCHNEPP takes over as Chairman of the Appointments, Governance and CSR Committee…
Nicox Announces First Patient in China screened in the ongoing NCX 470 Denali Phase 3 Trial in Glaucoma
Press Release Nicox Announces First Patient in China screened in the ongoing NCX 470…
Valneva Announces Positive Homologous Booster Data for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001
Initial results show excellent immune response after third dose of VLA2001 administered 7 to 8…
Issue of Shares to Employee Benefit Trust
This announcement contains inside information for the purposes of Article 7 of the Market Abuse…
Novartis initiates new USD 15 billion share buyback highlighting confidence in growth and pipeline
Ad hoc announcement pursuant to Art. 53 LR Share buyback of up to USD 15bn…
On substantial participation (4)
On December 15th, 2021 JSC Olainfarm has received announcement on substantial participation from AS AB…
FDA’s OTAT in Agreement With 12-Month Reduction in Pain as Primary Endpoint for Chronic Low Back Pain Program
NEW YORK, Dec. 15, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
Immix Biopharma, Inc. Announces Pricing of Initial Public Offering
LOS ANGELES, Dec. 15, 2021 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio” or the…
Antares Pharma Announces Divestiture of Otrexup®
EWING, N.J., Dec. 15, 2021 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”),…
Assertio Holdings, Inc. Announces the Acquisition of Otrexup® (methotrexate) a Drug Device Combination from Antares Pharma, Inc.
Trailing 12 Month Reported Revenues of Otrexup Were $15.5 Million Assertio will Pay Antares $18.0…
Universe Pharmaceuticals INC Appoints Mr. Baochang Liu as Chief Operating Officer
Ji’an, Jiangxi, China, Dec. 15, 2021 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (the “Company”) (Nasdaq:…
IBEX Reports Results for the First Quarter Ended October 31, 2021
MONTRÉAL, Dec. 15, 2021 (GLOBE NEWSWIRE) — IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX…
Lyell Immunopharma Announces cGMP Qualification of LyFE™ Manufacturing Center in Advance of Initiating Clinical Programs
Lyell’s cGMP-compliant manufacturing facility, is designed to produce cell products at scale for upcoming clinical…